Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
about
An increased total resected lymph node count benefits survival following pancreas invasive intraductal papillary mucinous neoplasms resection: an analysis using the surveillance, epidemiology, and end result registry databaseMain- and Branch-Duct Intraductal Papillary Mucinous Neoplasms: Extent of Surgical ResectionNatural History and Management of Intraductal Papillary Mucinous Neoplasms: Current EvidencePancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management optionsIncreased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literaturePancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery.Comparing methods for identifying pancreatic cancer patients using electronic data sources.Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreasMultidisciplinary management strategy for incidental cystic lesions of the pancreas.Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreasImaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN.Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative.Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasmSerum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis.Intraductal papillary mucinous neoplasm of the pancreas: an updateCurrent recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancerDetermination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formulaMucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms.Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms.Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment.Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.Cystic precursors to invasive pancreatic cancer.Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm.Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas.Natural history of asymptomatic pancreatic cystic neoplasms.One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinomaDetermining the natural history of pancreatic cystic neoplasms: a Manitoban cohort studyTherapeutic Approach to Cystic Neoplasms of the Pancreas.Stromal Fibrosis and Expression of Matricellular Proteins Correlate With Histological Grade of Intraductal Papillary Mucinous Neoplasm of the Pancreas.Management of mucin-producing cystic neoplasms of the pancreas.Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms.
P2860
Q21131945-9B12D463-F762-4EA9-8FA1-8E1D70D87EC2Q26796497-4EE55A7A-8134-406B-A51A-2D647EECC143Q26796500-041A46AF-8A88-4CE4-863C-9859ABBF233AQ26865466-D5DF806A-B379-4AF5-8E01-30BF12192830Q28080743-1B0F347A-210C-4035-BD7D-7608DB5079CFQ33596302-429B71AA-4E3A-410B-B318-4ABAB7077C70Q33828084-E9694A9B-C124-41D3-BA7F-6FCB621758C1Q33987127-A07B05DF-E0E2-4A71-8975-663941661006Q34093790-B04290F9-AD50-43E9-99C8-43AD0301C4DDQ34100230-3C354B45-FB48-4E0F-B794-762C95602FC2Q34240625-B8190BC6-495C-474E-B69A-3F1AD48C6D3CQ34391306-06D885B3-CA5A-42D7-AC08-0B7137B31CE5Q34438494-7E631892-5436-4F96-8F21-3C111BF1D73AQ34538828-28A7CF09-9397-41E8-848C-27BD2CDEC141Q34548931-CA5C3CA6-0CCF-4D36-9BA6-F31A43B4F405Q34602269-AC5406BD-CCB0-4604-8A87-1CBD59C65D3FQ34607328-01C115D4-FF38-43A4-9AFE-9A4E42836A07Q34657866-6B90413D-3E55-4A13-A005-1E7065ABB055Q35009641-74D0E53A-793A-4F38-82BB-B5C3E0D8A684Q35009837-052EDA6F-B35E-4FCC-BE8A-141CBFBA0E85Q35102198-BD53384A-7E1B-4325-B887-1EC166461BBBQ35152325-041B7659-78F3-4356-AB77-417669875840Q35167481-E600D9C2-D89B-45C4-ADB1-A511C50BDB1CQ35187065-A7D2280B-6E08-43B4-ADCC-71972FDBBFD8Q35583848-2F1B1134-E30A-4686-A2A7-DBC5DEF10CECQ35589994-E69D036A-17CE-4EEC-BB74-57DC471E3942Q35593104-19206086-C227-45BA-89DF-049473ED3CA6Q35609914-1BD4E941-DBE3-47DE-A3B7-9BBB4FB4EAF0Q35613897-E406B9A6-DC48-4852-9A93-641D441FB7D6Q36055277-2A867CE7-7FDE-40FE-BE89-1773C652FDF2Q36091569-19F4E3E2-559B-4E17-AEBE-3270CDB197CDQ36609351-AABFB68E-DD8E-42AF-A708-48BD39C4E69EQ36703314-7E072843-1A9D-49E4-95A1-2ED1973905B8Q36747321-C0EE11DB-B480-4551-B1B1-485F10FAD805Q36747331-DE9A5680-2954-4CD3-A836-29EE1293A805Q37191275-5BDF9EB2-B2CA-48AF-B521-257AE7F194F8Q37193860-A5A2AEE5-016E-4508-A019-1F75A80AAEABQ37249650-5B5DFFE5-2630-4422-8EF5-80F3B7CF80F6Q37279909-5B1C15D1-05E9-4A43-919F-0010E51EAD38Q37612257-69BE635F-9579-4C7B-8CC9-35F7F43DAFCF
P2860
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@ast
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@en
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@nl
type
label
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@ast
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@en
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@nl
prefLabel
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@ast
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@en
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@nl
P2093
P1433
P1476
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
@en
P2093
Atilla Nakeeb
C Max Schmidt
Fatih M Akisik
Henry A Pitt
John M DeWitt
Joshua A Waters
Keith D Lillemoe
Marshall Baker
Nicholas J Zyromski
Oscar W Cummings
P304
644-51; discussion 651-4
P356
10.1097/SLA.0B013E318155A9E5
P407
P577
2007-10-01T00:00:00Z